U.S. Markets close in 4 hrs, 34 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,016.09 | -42.55 | -0.42% |
| NASDAQ | 2,139.27 | -11.60 | -0.54% |
| S&P 500 | 1,065.40 | -5.12 | -0.48% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 19.1719 10:06 AM EST | |
|---|---|---|
| Day High | 19.42 09:30 AM EST |
|
| Range | 0.25 |
| Volume | 11,883 | |
|---|---|---|
| 30-Day Avg Vol | 113,000 |
|
| Difference | -89.48% |
| Market Cap | 288.10 M | |
|---|---|---|
| Mkt Cap Chg | -1.48 M |
| Shares Out | 14.88 M | |
|---|---|---|
| % Shrs Traded | 0.08% | |
| 1yr EPS Est | 1.481 |
| 52-Wk Low | 8.28 | |
|---|---|---|
| 52-Wk High | 23.54 |
|
| Range | 15.26 |
| Prev Close | 19.46 2/9/10 | |
|---|---|---|
| Today's Open | 19.42 | |
| Change | -0.21% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 782,061.00 |
| Revenue (LFY) | 678.58 M | |
|---|---|---|
| Earnings (LFY) | 29.40 M | |
| Earnings (MRQ) | 8.83 M | |
| Next Earn Est | 0.399 | |
| Next Earnings | 02/22/2010 |
|
| EPS (TTM) | 1.19 | |
| 1yr EPS Growth | -23.66% |
| P/E Ratio (TTM) | 12.91 | |
|---|---|---|
| P/E Ratio (Fwd) | 13.00 | |
| PEG Ratio | 0.80 | |
| Return on Equity | 18.11 | |
| Beta | 1.03 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
When it comes to research and development, few can hold a candle to Kendle International. A leading contract research organization (CRO) for the biotechnology and pharmaceutical industries, the company ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.399 2/22/10 | — — |
—
—
|
| Last Quarter | 0.379 9/30/09 | 0.71 9/30/09 |
0.331
Beat
|
| 2 Quarters Ago | 0.324 6/30/09 | 0.43 6/30/09 |
0.106
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 133.76 M | 678.58 M |
| Gross Profit | 51.77 M | 212.40 M |
| Operating Income | 15.91 M | 56.83 M |
| Net Income | 8.83 M | 29.40 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts